Who owns ALX ONCOLOGY HOLDINGS INC?
Prices and market caps: Cboe delayed data, at least 15 minutes delayed. Not real-time. Fundamentals from company filings.
Institutional ownership of ALXO from SEC Form 13F filings across 112 reporting managers. All positions are from one synchronized reporting period — 2026-09-30 books, filed up to 45 days after quarter end — so every row is comparable.
As of the 2026-09-30 reporting period, 112 institutions disclosed 105.9M shares of ALX ONCOLOGY HOLDINGS INC worth $147.1M — about 75.1% of shares outstanding; the largest disclosed holder is RA CAPITAL MANAGEMENT, L.P.. Source: SEC Form 13F filings, parsed by EvidInvest.
112
13F holders
$147.1M
value, 2026 filers
75.1%
of shares outstanding (105.9M sh)
23
new positions (2026 filers)
Top institutional holders
ordered by shares owned · positions as of 2026-09-30 · % of fund = share of the manager's own book · % of co. = share of ALXO's shares outstanding
| # | Manager | Shares | Value | % of fund | % of co. | Δ shares QoQ |
|---|---|---|---|---|---|---|
| 1 | RA CAPITAL MANAGEMENT, L.P. | 13.0M | $18.1M | 0.2% | 9.2% | 0.0% |
| 2 | venBio Partners LLC | 12.9M | $17.9M | 3.6% | 9.1% | 0.0% |
| 3 | BlackRock, Inc. | 7.7M | $10.7M | 0.0% | 5.5% | +4.2% |
| 4 | Redmile Group, LLC | 7.2M | $10.0M | 0.7% | 5.1% | -2.8% |
| 5 | Blackstone Inc. | 6.8M | $9.4M | 0.0% | 4.8% | +2.8% |
| 6 | SILVERARC CAPITAL MANAGEMENT, LLC | 6.6M | $9.1M | 1.1% | 4.7% | +14.3% |
| 7 | Driehaus Capital Management LLC | 6.0M | $8.4M | 0.1% | 4.3% | 0.0% |
| 8 | VANGUARD CAPITAL MANAGEMENT LLC | 4.7M | $6.6M | 0.0% | 3.4% | -4.5% |
| 9 | MARSHALL WACE, LLP | 3.1M | $4.4M | 0.0% | 2.2% | +2.5% |
| 10 | 5AM Venture Management, LLC | 3.1M | $4.2M | 1.4% | 2.2% | 0.0% |
| 11 | ORBIMED ADVISORS LLC | 2.7M | $3.8M | 0.1% | 1.9% | -4.3% |
| 12 | TCG Crossover Management, LLC | 2.5M | $3.4M | 0.1% | 1.7% | -56.4% |
| 13 | GEODE CAPITAL MANAGEMENT, LLC | 2.4M | $3.3M | 0.0% | 1.7% | -13.6% |
| 14 | MILLENNIUM MANAGEMENT LLC | 2.4M | $3.3M | 0.0% | 1.7% | +52.6% |
| 15 | STATE STREET CORP | 2.1M | $2.9M | 0.0% | 1.5% | +37.6% |
| 16 | Almitas Capital LLC | 2.0M | $2.8M | 0.6% | 1.4% | -30.5% |
| 17 | TWO SIGMA INVESTMENTS, LP | 2.0M | $2.8M | 0.0% | 1.4% | -6.8% |
| 18 | ACADIAN ASSET MANAGEMENT LLC | 1.4M | $2.0M | 0.0% | 1% | +9.0% |
| 19 | GOLDMAN SACHS GROUP INC | 1.4M | $2.0M | 0.0% | 1% | +89.4% |
| 20 | Squadron Capital Management LLCNEW | 1.4M | $1.9M | 0.5% | 1% | new |
| 21 | FMR LLC | 1.3M | $1.9M | 0.0% | 1% | +10053.9% |
| 22 | AQR CAPITAL MANAGEMENT LLCNEW | 1.2M | $1.7M | 0.0% | 0.9% | new |
| 23 | JPMORGAN CHASE & CO | 1.0M | $1.4M | 0.0% | 0.7% | -1.2% |
| 24 | Atom Investors LP | 1.0M | $1.4M | 0.1% | 0.7% | +368.4% |
| 25 | NORTHERN TRUST CORP | 833,078 | $1.2M | 0.0% | 0.6% | -11.0% |
Source: SEC Form 13F-HR filings (institutional managers over $100M in US-listed positions). 13Fs disclose long positions only, up to 45 days after quarter end; each manager's latest filed quarter is shown per row and dollar values are the manager's filed marks. Aggregates labeled "2026 filers" count only managers whose latest book is a 2026 quarter. Related: valuation · options positioning · supply chain. Research, not investment advice.